azaribine azaribine azaribine (triacetyl-6-azauridine) is a drug which was developed for the treatment of psoriasis, and also has anti-cancer and antiviral actions. it is a prodrug which is metabolised to the nucleoside analogue 6-azauridine in the body. azaribine was approved for clinical use in treatment of psoriasis, but subsequently withdrawn because of toxicity issues, however it continues to be researched as a potential agent for the treatment of emerging viral diseases. azaribineclinical datatrade namesazaribinelegal statuslegal status us: withdrawn drug identifiers iupac name methyl acetate cas number2169-64-4pubchem cid16574chemspider15714uniik1u80do9ebkeggd03029chebichebi:88272chemblchembl515914comptox dashboard (epa)dtxsid1022635 echa infocard100.016.832 chemical and physical dataformulac14h17n3o9molar mass371.3 g·mol−13d model (jsmol)interactive image smiles cc(=o)oc1(((o1)n2c(=o)nc(=o)c=n2)oc(=o)c)oc(=o)c inchi inchi=1s/c14h17n3o9/c1-6(18)23-5-9-11(24-7(2)19)12(25-8(3)20)13(26-9)17-14(22)16-10(21)4-15-17/h4,9,11-13h,5h2,1-3h3,(h,16,21,22)/t9-,11-,12-,13-/m1/s1key:qqobrrfovwgimd-ojakkhqrsa-n